Mechanisms involved in the development of resistance to fluoroquinolones in Escherichia coli isolates

Journal of Antimicrobial Chemotherapy

Volumn 44, Issue 6, 1999, Pages 735-742

  Del Mar Tavío, María ^a   Vila, Jordi ^b   Ruiz, Joaquím ^b   Ruiz, José ^a   Martín Sánchez, Antonio Manuel ^a   Jiménez De Anta, María Teresa ^b  

^a UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CEFALOTIN; CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING); LOMEFLOXACIN; NALIDIXIC ACID; NORFLOXACIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN; TEMAFLOXACIN; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; ESCHERICHIA COLI; GENE MUTATION; NONHUMAN; PHENOTYPE;

EID: 0032805684     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/44.6.735     Document Type: Article

References (22)

1. Everett, M. J., Jin, Y. F., Ricci, V. & Piddock, L. J. V. (1996). Contributions of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals. Antimicrobial Agents and Chemotherapy 40, 2380-6.
2. Hallett, P. & Maxwell, A. (1991). Novel quinolone resistance mutations of the Escherichia coli DNA gyrase A protein: enzymatic analysis of the mutant proteins. Antimicrobial Agents and Chemotherapy 35, 335-40.
3. Oram, M. & Fisher, L. M. (1991). 4-Quinolone resistance mutations in the DNA gyrase of Escherichia coli clinical isolates identified by using the polymerase chain reaction. Antimicrobial Agents and Chemotherapy 35, 387-9.
4. Piddock, L. J. V. (1995). Mechanisms of resistance to fluoroquinolones: state-of-the-art 1992-1994. Drugs 49, Suppl. 2, 29-35.
5. Vila, J., Ruiz, J., Marco, F., Barceló, A., Goñi, P., Giralt, E. et al. (1994). Association between double mutation in the gyrA gene of ciprofloxacin-resistant clinical isolates of Escherichia coli and MICs. Antimicrobial Agents and Chemotherapy 38, 2477-9.
6. Vila J., Ruiz, J., Goñi, P. & de Jiménez Anta, M.T. (1996). Detection of mutations in parC in quinolone-resistant clinical isolates of Escherichia coli. Antimicrobial Agents and Chemotherapy 40, 491 -3.
7. Breines, D. M., Ouabdesselam, S., Ng, E. Y., Tankovic, J., Shah, S., Soussy, C. J. et al. (1997). Quinolone resistance locus nfxD of Escherichia coli is a mutant allele of the parE gene encoding a subunit of topoisomerase IV. Antimicrobial Agents and Chemotherapy 41, 175-9.
8. Mortimer, P. G. S. & Piddock, L. J. V. (1993). The accumulation of five antibacterial agents in porin-deficient mutants of Escherichia coli. Journal of Antimicrobial Chemotherapy 32, 195-213.
9. Hirai, K., Aoyama, H., Irikura, T., Iyobe, S. & Mitsuhashi, S. (1986). Differences in susceptibility to quinolones of outer membrane mutants of Salmonella typhimurium and Escherichia coli. Antimicrobial Agents and Chemotherapy 29, 535-8.
10. Moniot-Ville, N., Guibert, J., Moreau, N., Acar, J. F., Collatz, E. & Gutmann, L. (1991). Mechanisms of quinolone resistance in a clinical isolate of Escherichia coli highly resistant to fluoroquinolones but susceptible to nalidixic acid. Antimicrobial Agents and Chemotherapy 35, 519-23.
11. Paulsen, I. T., Brown, M. H. & Skurray, R. A. (1996). Proton-dependent multidrug efflux systems. Microbiological Reviews 60, 575-608.
12. Cohen, S. P., McMurry, L. M., Hooper, D. C., Wolfson, J. S. & Levy, S. B. (1989). Cross-resistance to fluoroquinolones in multiple-antibiotic-resistant (Mar) Escherichia coli selected by tetracycline or chloramphenicol: decreased drug accumulation associated with membrane changes in addition to OmpF reduction. Antimicrobial Agents and Chemotherapy 33, 1318-25.
13. Okusu, H., Ma, D. & Nikaido, H. (1996). AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic-resistance (Mar) mutants. Journal of Bacteriology 178, 306-8.
14. Hooper, D. C., Wolfson, J. S., Souza, K. S., Tung, C., McHugh, G. L. & Swartz, M. N. (1986). Genetic and biochemical characterization of norfloxacin resistance in Escherichia coli. Antimicrobial Agents and Chemotherapy 29, 639-44.
15. National Committee for Clinical Laboratory Standards. (1993). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically-Third Edition: Approved Standard M7-A3. NCCLS, Villanova, PA.
16. Ruiz, J., Casellas, S., Jiménez de Anta, M. T. & Vila, J. (1997). The region of the parE gene, homologous to the quinolone-resistant determining region of the gyrB gene, is not linked with the acquisition of quinolone resistance in Escherichia coli clinical isolates. Journal of Antimicrobial Chemotherapy 39, 839-40.
17. Sawai, T., Hiruma, R., Kawana, N., Kaneko, M., Taniyasu, F. & Inami, A. (1982). Outer membrane permeation of β-lactam anti-biotics in Escherichia coli, Proteus mirabilis, and Enterobacter cloacae. Antimicrobial Agents and Chemotherapy 22, 585-92.
18. Hitchcock, P. J. & Brown, T. M. (1983). Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels. Journal of Bacteriology 154, 269-77.
19. Tsai, C.-M. & Frasch, C. E. (1982). A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. Annals of Biochemistry 119, 115-9.
20. Hirai, K., Aoyama, H., Suzue, S., Irikura, T., Iyobe, S. & Mitsuhashi, S. (1986). Isolation and characterization of norfloxacin-resistant mutants of Escherichia coli K-12. Antimicrobial Agents and Chemotherapy 30, 248-53.
21. Ishii, H., Sato, K., Hoshino, K., Sato, M., Yamaguchi, A., Sawai, T. et al. (1991). Active efflux of ofloxacin by a highly quinolone-resistant strain of Proteus vulgaris. Journal of Antimicrobial Chemotherapy 28, 827-36.
22. Ma, D., Cook, D. N., Alberti, M., Pon, N. G., Nikaido, H. & Hearst, J. E. (1995). Genes acrA and acrB encode a stress-induced efflux system of Escherichia coli. Molecular Microbiology 16, 45-55.